Parmax Pharma Ltd. News, Corporate filings and Earnings/Conference Calls

Keep track of all breaking news and updates on Parmax Pharma Ltd. from all sources in a single place.

Load latest

Parmax Pharma Ltd.

12 Aug 2022

33.90

-0.09%

Board Meeting

Parmax Pharma Ltd - 540359 - Board Meeting Outcome for Outcome Of The Meeting Of The …

BSE India

Board of Directors of the Company has, at its meeting held today, inter-alia, considered and approved the Unaudited Financial Results for quarter ended 30th June, 2022.

pdf

Parmax Pharma Ltd.

10 Aug 2022

33.90

-0.09%

Company Update

Parmax Pharma Ltd - 540359 - Update on board meeting

BSE India

The Board Meeting to be held on 11/08/2022 has been revised to 12/08/2022 Meeting of the Board of Directors of the Company is rescheduled on 12th August, 2022, the Friday to consider and approve Financial Results for the quarter ended 30th June, 2022.

pdf

Parmax Pharma Ltd.

04 Aug 2022

33.90

-0.09%

Board Meeting

Parmax Pharma Ltd - 540359 - Board Meeting Intimation for Intimation Of Board Meeting In Compliance …

BSE India

Parmax Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2022 ,inter alia, to consider and approve Intimation of Board Meeting in compliance with Reg. 29 read with Reg. 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

pdf

Parmax Pharma Ltd.

15 Jul 2022

33.90

-0.09%

Company Update

Parmax Pharma Ltd - 540359 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended 30th June, 2022

pdf

Parmax Pharma Ltd.

05 Jul 2022

33.90

-0.09%

Company Update

Parmax Pharma Ltd - 540359 - Statement Of Investor Complaints For The Quarter Ended June 2022

BSE India

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- YASH VORADesignation :- Company Secretary and Compliance Officer

Parmax Pharma Ltd.

29 Jun 2022

33.90

-0.09%

SAST

Parmax Pharma Ltd - 540359 - Closure of Trading Window

BSE India

Closure of trading window

pdf

Parmax Pharma Ltd.

24 Jun 2022, 07:05PM

33.90

-0.09%

Company Update

Parmax Pharma Ltd - 540359 - Clarification On Price Movement.

BSE India

Clarification on Price Movement.

pdf

Parmax Pharma Ltd.

24 Jun 2022

33.90

-0.09%

Company Update

Parmax Pharma Ltd - 540359 - Clarification sought from Parmax Pharma Ltd

BSE India

The Exchange has sought clarification from Parmax Pharma Ltd on June 23, 2022 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.The reply is awaited.